Helena Cortez‐Pinto

Mapping the NASH-CHECK to the EQ-5D-5L in a MASLD population in seven European countries

Abstract Background Metabolic-dysfunction associated steatotic liver disease (MASLD) is a progressive chronic liver condition characterised by substantial inter-patient variation in disease severity, with the probability of progressing to hepatic fibrosis, cirrhosis or hepatocell...